论文部分内容阅读
骨质疏松症(osteoporosis,OP)作为一种全身性疾病,其特征是骨量减少,骨组织微结构破坏,使得骨脆性增加而易骨折。OP多发于绝经后妇女和老年人,其发病率呈逐年上升的趋势,已成为重要的公共卫生问题~([1])。尽管近年来我国OP的诊治水平已取得长足进步,但仍然存在诊断率低、疗效差、治疗依从性差,复诊率较低等问题,造成该问题的原因较复杂,可能与抗OP药物尚缺乏有效方便的监测指标,影响了临床疗效,患者对治疗缺乏信任等有关。因此,如何通过监测
Osteoporosis (OP), as a systemic disease, is characterized by decreased bone mass and destruction of the microstructure of bone tissue, resulting in increased bone fragility and fracture. The prevalence of OP in the postmenopausal women and the elderly is increasing year by year, which has become an important public health issue ([1]). Although the diagnosis and treatment of OP have made great progress in recent years, there are still some problems such as low diagnostic rate, poor curative effect, poor treatment compliance and low referral rate. The causes of this problem are complex and may be related to the lack of effective anti-OP drugs Convenient monitoring indicators, affecting the clinical efficacy of patients with lack of trust and treatment related. So how to pass the monitoring